JAM
ICPT

Jupiter Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jupiter Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-472,847
Closed -$5.22M – 609
2023
Q2 		$5.22M Buy
472,847
+32,094
+7% +$447K 0.06% 277
2023
Q1 		$5.91M Buy
440,753
+19,158
+5% +$331K 0.08% 208
2022
Q4 		$5.22M Buy
421,595
+78,954
+23% +$1.12M 0.08% 220
2022
Q3 		$4.78M Buy
342,641
+15,088
+5% +$243K 0.07% 244
2022
Q2 		$4.52M Buy
327,553
+10,341
+3% +$166K 0.06% 250
2022
Q1 		$5.15M Buy
+317,212
New +$4.97M 0.06% 252

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Jupiter Asset Management's ICPT Position: Q3 2023 in Review

Jupiter Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 472,847 shares — an estimated $5.22M sold.

Jupiter Asset Management first reported a position in ICPT in Q1 2022 and held it in 6 quarters. The position peaked at $5.91M in Q1 2023. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Jupiter Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Jupiter Asset Management sold 472,847 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $5.22M.
  • Jupiter Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2022 and held it in 6 quarters.
  • Jupiter Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $5.91M in Q1 2023.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Jupiter Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.